High lipoprotein (A) levels do not exacerbate aortic valve velocity in a group of fh subjects von Narverud, I., Bogsrud, M.P., Hovland, A., Aagnes, I., Langslet, G., Retterstøl, K., Wium, C., Svilaas, A., Arnesen, K.E., Øyri, L.K.L., Aukrust, P., Halvorsen, B., Yndestad, A., Ulven, S.M., Holven, K.B.

Volltext

Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke von Sletnes, K.E., Wisløff, F., Smith, P., Arnesen, H., Abdelnoor, M.

Volltext

Antiphospholipid antibodies and recurrent thrombo-occlusive events von Levine, StevenR, Brey, RobinL, Kittner, StevenJ, Sletnes, K.E., Smith, P., Abdelnoor, M., Arnesen, H., Wisløff, F.

Volltext